Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal of Cancer|April 20, 2012
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancerGordana Halec, Markus Schmitt, Bolormaa Dondog, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16Uzma A Hasan, Elizabeth Bates, Fumihiko Takeshita, et al.
Plos One|July 5, 2012
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidateKaren Nieto, Margit Weghofer, Peter Sehr, et al.
Plos Pathogens|January 12, 2018
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in miceDaniele Viarisio, Karin Müller-Decker, Rosita Accardi, et al.
Cancer Research|May 6, 2004
Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancerGopeshwar Narayan, Hugo Arias-Pulido, Subhadra V Nandula, et al.
Genes, Chromosomes & Cancer|January 24, 2007
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genesGopeshwar Narayan, Veronique Bourdon, Seeta Chaganti, et al.
The Journal of Pathology|July 22, 2014
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancerGordana Halec, Laia Alemany, Belen Lloveras, et al.
Oncogene|May 31, 2003
Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progressionGopeshwar Narayan, Hugo Arias Pulido, Sanjay Koul, et al.
Plos Pathogens|April 11, 2009
Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaquesChristiane Stahl-Hennig, Martin Eisenblätter, Edith Jasny, et al.
International Journal of Cancer|August 28, 2007
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)Andreas M Kaufmann, John D Nieland, Ingrid Jochmus, et al.
Pageof 7